The Alzheimer's Drug Discovery Foundation has announced a matching gift from Melvin R. Goodes and his family to create what the foundation is calling the first prize to specifically recognize scientists pursuing innovative Alzheimer's drug discovery research.
To that end, Goodes and his wife, Nancy, have committed $750,000 for the prize through the Goodes Family Foundation, which ADDF will match, creating a funding pool that will support the annual prize program for ten years. To be awarded to a professionally active researcher who has made a significant and lasting impact in the field of Alzheimer's drug discovery, the Goodes Prize will include a $150,000 cash award in support of the winner's future research.
The former chairman and CEO of Warner-Lambert, Goodes has been diagnosed with Alzheimer's disease and is an honorary member of ADDF's board of governors.
"We are grateful to the Goodes family for spearheading the creation of this prize, which supports the valiant efforts of scientists dedicated to conquering Alzheimer's," said Howard Fillit, founding executive director and chief scientific officer of ADDF. "These researchers are making critical contributions toward effective treatments and a cure for this devastating disease, and their work often goes unrecognized."